• Charles River Laboratories (Wilmington, Massachusetts) discussed planned management changes which will be implemented over the course of 2015. Thomas Ackerman, Corporate Executive VP and CFO, has said that following a transition period, he will retire from Charles River Laboratories in February 2016. David Smith, Corporate Senior VP, Global Discovery Services, has been named as Ackerman's successor. Smith joined Charles River through the acquisition of Argenta and BioFocus from Galapagos NV, where he was serving as CEO of its Galapagos Services division.

• Epic Sciences (San Diego) has named Chris Bernard as chief commercial officer. Bernard has more than 20 years of experience as a senior executive and company officer leading sales and marketing teams to build biopharma and translational research partnerships and commercialize IVD platforms.

No Comments